These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31724824)

  • 1. PRC2-complex related dysfunction in overgrowth syndromes: A review of EZH2, EED, and SUZ12 and their syndromic phenotypes.
    Cyrus S; Burkardt D; Weaver DD; Gibson WT
    Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):519-531. PubMed ID: 31724824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EED related overgrowth: First report of multiple members in a single family.
    Goel H; O'Donnell S; Edwards M
    Am J Med Genet A; 2024 Feb; 194(2):374-382. PubMed ID: 37840385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in genes encoding polycomb repressive complex 2 subunits cause Weaver syndrome.
    Imagawa E; Higashimoto K; Sakai Y; Numakura C; Okamoto N; Matsunaga S; Ryo A; Sato Y; Sanefuji M; Ihara K; Takada Y; Nishimura G; Saitsu H; Mizuguchi T; Miyatake S; Nakashima M; Miyake N; Soejima H; Matsumoto N
    Hum Mutat; 2017 Jun; 38(6):637-648. PubMed ID: 28229514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EED and EZH2 constitutive variants: A study to expand the Cohen-Gibson syndrome phenotype and contrast it with Weaver syndrome.
    Griffiths S; Loveday C; Zachariou A; Behan LA; Chandler K; Cole T; D'Arrigo S; Dieckmann A; Foster A; Gibney J; Hunter M; Milani D; Pantaleoni C; Roche E; Sherlock M; Springer A; White SM; ; Tatton-Brown K
    Am J Med Genet A; 2019 Apr; 179(4):588-594. PubMed ID: 30793471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare SUZ12 variants commonly cause an overgrowth phenotype.
    Cyrus SS; Cohen ASA; Agbahovbe R; Avela K; Yeung KS; Chung BHY; Luk HM; Tkachenko N; Choufani S; Weksberg R; Lopez-Rangel E; ; Brown K; Saenz MS; Svihovec S; McCandless SE; Bird LM; Garcia AG; Gambello MJ; McWalter K; Schnur RE; An J; Jones SJM; Bhalla SK; Pinz H; Braddock SR; Gibson WT
    Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):532-547. PubMed ID: 31736240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Methylation Signature for EZH2 Functionally Classifies Sequence Variants in Three PRC2 Complex Genes.
    Choufani S; Gibson WT; Turinsky AL; Chung BHY; Wang T; Garg K; Vitriolo A; Cohen ASA; Cyrus S; Goodman S; Chater-Diehl E; Brzezinski J; Brudno M; Ming LH; White SM; Lynch SA; Clericuzio C; Temple IK; Flinter F; McConnell V; Cushing T; Bird LM; Splitt M; Kerr B; Scherer SW; Machado J; Imagawa E; Okamoto N; Matsumoto N; Testa G; Iascone M; Tenconi R; Caluseriu O; Mendoza-Londono R; Chitayat D; Cytrynbaum C; Tatton-Brown K; Weksberg R
    Am J Hum Genet; 2020 May; 106(5):596-610. PubMed ID: 32243864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of maternal EED results in postnatal overgrowth.
    Prokopuk L; Stringer JM; White CR; Vossen RHAM; White SJ; Cohen ASA; Gibson WT; Western PS
    Clin Epigenetics; 2018 Jul; 10(1):95. PubMed ID: 30005706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imagawa-Matsumoto syndrome: SUZ12-related overgrowth disorder.
    Imagawa E; Seyama R; Aoi H; Uchiyama Y; Marcarini BG; Furquim I; Honjo RS; Bertola DR; Kim CA; Matsumoto N
    Clin Genet; 2023 Apr; 103(4):383-391. PubMed ID: 36645289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biallelic loss-of-function variants of EZH1 cause a novel developmental disorder with central precocious puberty.
    Okamoto N; Yoshida S; Ogitani A; Etani Y; Yanagi K; Kaname T
    Am J Med Genet A; 2024 May; ():e63726. PubMed ID: 38814056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weaver Syndrome-Associated EZH2 Protein Variants Show Impaired Histone Methyltransferase Function In Vitro.
    Cohen AS; Yap DB; Lewis ME; Chijiwa C; Ramos-Arroyo MA; Tkachenko N; Milano V; Fradin M; McKinnon ML; Townsend KN; Xu J; Van Allen MI; Ross CJ; Dobyns WB; Weaver DD; Gibson WT
    Hum Mutat; 2016 Mar; 37(3):301-7. PubMed ID: 26694085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezh2 Mutations Found in the Weaver Overgrowth Syndrome Cause a Partial Loss of H3K27 Histone Methyltransferase Activity.
    Lui JC; Barnes KM; Dong L; Yue S; Graber E; Rapaport R; Dauber A; Nilsson O; Baron J
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1470-1478. PubMed ID: 29244146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manifestation of epilepsy in a patient with EED-related overgrowth (Cohen-Gibson syndrome).
    Hetzelt KLML; Winterholler M; Kerling F; Rauch C; Ekici AB; Winterpacht A; Vasileiou G; Uebe S; Thiel CT; Kraus C; Reis A; Zweier C
    Am J Med Genet A; 2022 Jan; 188(1):292-297. PubMed ID: 34533271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
    Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K
    Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weaver syndrome and EZH2 mutations: Clarifying the clinical phenotype.
    Tatton-Brown K; Murray A; Hanks S; Douglas J; Armstrong R; Banka S; Bird LM; Clericuzio CL; Cormier-Daire V; Cushing T; Flinter F; Jacquemont ML; Joss S; Kinning E; Lynch SA; Magee A; McConnell V; Medeira A; Ozono K; Patton M; Rankin J; Shears D; Simon M; Splitt M; Strenger V; Stuurman K; Taylor C; Titheradge H; Van Maldergem L; Temple IK; Cole T; Seal S; ; Rahman N
    Am J Med Genet A; 2013 Dec; 161A(12):2972-80. PubMed ID: 24214728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma.
    Wasenang W; Puapairoj A; Settasatian C; Proungvitaya S; Limpaiboon T
    Pathol Res Pract; 2019 Jul; 215(7):152451. PubMed ID: 31126817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia.
    Schäfer V; Ernst J; Rinke J; Winkelmann N; Beck JF; Hochhaus A; Gruhn B; Ernst T
    J Cancer Res Clin Oncol; 2016 Jul; 142(7):1641-50. PubMed ID: 27169594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs.
    Zhao Y; Guan YY; Zhao F; Yu T; Zhang SJ; Zhang YZ; Duan YC; Zhou XL
    Eur J Med Chem; 2022 Mar; 231():114144. PubMed ID: 35093670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel SUZ12 mutations in Weaver-like syndrome.
    Imagawa E; Albuquerque EVA; Isidor B; Mitsuhashi S; Mizuguchi T; Miyatake S; Takata A; Miyake N; Boguszewski MCS; Boguszewski CL; Lerario AM; Funari MA; Jorge AAL; Matsumoto N
    Clin Genet; 2018 Nov; 94(5):461-466. PubMed ID: 30019515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three additional patients with EED-associated overgrowth: potential mutation hotspots identified?
    Spellicy CJ; Peng Y; Olewiler L; Cathey SS; Rogers RC; Bartholomew D; Johnson J; Alexov E; Lee JA; Friez MJ; Jones JR
    J Hum Genet; 2019 Jun; 64(6):561-572. PubMed ID: 30858506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant Peripheral Nerve Sheath Tumors: From Epigenome to Bedside.
    Korfhage J; Lombard DB
    Mol Cancer Res; 2019 Jul; 17(7):1417-1428. PubMed ID: 31023785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.